Get started
Author

Russell R. Gotschall

Observed names: R GOTSCHALL, R Gotschall, R R Gotschall, R. Gotschall, R. R. Gotschall, R. Russell Gotschall, R.Russell Gotschall, Russel Gotschall, Russell Gotschall, Russell Gotshall
Observed institutions: University of North Carolina at Chapel Hill, Children's Mercy Hospital, Oklahoma Department of Transportation, Medical College of Wisconsin, Oklahoma City Community College, Wichita State University, Amicus Therapeutics (United States), Erasmus MC - Sophia Children’s Hospital, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bassett Healthcare Network, Bassett Medical Center, Morehouse School of Medicine, University of Missouri–Kansas City
ORCID: 0000-0002-5050-1386
Observed ORCID: 0000-0002-5050-1386
OpenAlex ID: A5060284076
Klotho Inhibits Transforming Growth Factor-β1 (TGF-β1) Signaling and Suppresses Renal Fibrosis and Cancer Metastasis in Mice
2011 · Shigehiro Doi, Yonglong Zou, et al. · Journal of Biological Chemistry · 552
PDF
Optimization of cytochrome P4502D6 (CYP2D6) phenotype assignment using a genotyping algorithm based on allele frequency data
1999 · Andrea Gaedigk, R. Russell Gotschall, et al. · Pharmacogenetics and Genomics · 183
Structural features of mammalian gonadotropins
1996 · George R. Bousfield, Viktor Y. Butnev, et al. · Molecular and Cellular Endocrinology · 113
Biochemical and pharmacological characterization of different recombinant acid α-glucosidase preparations evaluated for the treatment of Pompe disease
2008 · A.J. McVie-Wylie, K.L. Lee, et al. · Molecular Genetics and Metabolism · 99
Improved efficacy of a next-generation ERT in murine Pompe disease
2019 · Su Xu, Yi Lun, et al. · JCI Insight · 92
PDF
Quantitation of three-month intraindividual variability and influence of sex and menstrual cycle phase on CYP1A2, N-acetyltransferase-2, and xanthine oxidase activity determined with caffeine phenotyping*
1998 · Angela D.M. Kashuba, Joseph S. Bertino, et al. · Clinical Pharmacology & Therapeutics · 86
Investigation of terbinafine as a CYP2D6 inhibitor in vivo
1999 · S ABDELRAHMAN, R GOTSCHALL, et al. · Clinical Pharmacology & Therapeutics · 82
Cation-independent Mannose 6-Phosphate Receptor
2009 · Richard N. Bohnsack, Xuezheng Song, et al. · Journal of Biological Chemistry · 76
PDF
Challenges in treating Pompe disease: an industry perspective
2019 · Hung V. Do, Richie Khanna, et al. · Annals of Translational Medicine · 74
PDF
Quantification of intraindividual variability and the influence of menstrual cycle phase on CYP2D6 activity as measured by dextromethorphan phenotyping
1998 · Angela D.M Kashuba, Anne N. Nafziger, et al. · Pharmacogenetics · 71
Effect of fluvoxamine therapy on the activities of CYP1A2, CYP2D6, and CYP3A as determined by phenotyping*
1998 · Angela D.M. Kashuba, Anne N. Nafziger, et al. · Clinical Pharmacology & Therapeutics · 67
Hyaluronan Biosynthesis by Class I Streptococcal Hyaluronan Synthases Occurs at the Reducing End
2005 · Valarie L. Tlapak-Simmons, Christina A. Baron, et al. · Journal of Biological Chemistry · 62
Concordance between Tramadol and Dextromethorphan Parent/Metabolite Ratios: The Influence of CYP2D6 and Non‐CYP2D6 Pathways on Biotransformation
2002 · S. M. Abdel‐Rahman, J. S. Leeder, et al. · The Journal of Clinical Pharmacology · 60
Potent Inhibition of Cytochrome P-450 2D6-Mediated DextromethorphanO-Demethylation by Terbinafine
1999 · Susan M. Abdel-Rahman, Kenda Marcucci, et al. · Drug Metabolism and Disposition · 56
Domain 5 of the Cation-Independent Mannose 6-Phosphate Receptor Preferentially Binds Phosphodiesters (Mannose 6-Phosphate N-Acetylglucosamine Ester)
2007 · Carrie A. Chavez, Richard N. Bohnsack, et al. · Biochemistry · 47
Strategies for Neoglycan Conjugation to Human Acid α-Glucosidase
2011 · Qun Zhou, James E. Stefano, et al. · Bioconjugate Chemistry · 45
Structural basis for recognition of phosphodiester-containing lysosomal enzymes by the cation-independent mannose 6-phosphate receptor
2010 · Linda J. Olson, Francis C. Peterson, et al. · Proceedings of the National Academy of Sciences · 45
Carbohydrate Analysis of Glycoprotein Hormones
2000 · George R. Bousfield, Vanda L. Baker, et al. · Methods · 45
Cytochrome P450 Involvement in the biotransformation of cisapride and racemic norcisapride in vitro: differential activity of individual human CYP3A isoforms.
2001 · R E Pearce, R R Gotschall, et al. · PubMed · 40
Role of TGF-β in a Mouse Model of High Turnover Renal Osteodystrophy
2013 · Shiguang Liu, Wenping Song, et al. · Journal of Bone and Mineral Research · 38
PDF
Negative influence of O-linked oligosaccharides of high molecular weight equine chorionic gonadotropin on its luteinizing hormone and follicle-stimulating hormone receptor-binding activities
1996 · V Y Butnev, R R Gotschall, et al. · Endocrinology · 34
Optimization of cytochrome P4502D6 (CYP2D6) phenotype assignment using a genotyping algorithm based on allele frequency data
1999 · Andrea Gaedigk, R. Russell Gotschall, et al. · Pharmacogenetics · 30
Endolysosomal N-glycan processing is critical to attain the most active form of the enzyme acid alpha-glucosidase
2021 · Nithya Selvan, Nickita Mehta, et al. · Journal of Biological Chemistry · 25
PDF
Oligosaccharide mapping reveals hormone-specific glycosylation patterns on equine gonadotropin alpha-subunit Asn56
1996 · R R Gotschall, G R Bousfield · Endocrinology · 22
Hormone-Specific Inhibitory Influence of α-Subunit Asn56 Oligosaccharide on In Vitro Subunit Association and Follicle-Stimulating Hormone Receptor Binding of Equine Gonadotropins1
1998 · Viktor Y. Butney, R. Russell Gotschall, et al. · Biology of Reproduction · 21
Works count: 67
Citation count: 2,131
H-index: 23
I10-index: 27
Year
Topic
Type